In Brief: Copley
This article was originally published in The Tan Sheet
Executive Summary
Copley: Canton, Mass.-based generic drug company taps Gabriel Cipau, PhD, as president and CEO. Formerly president and CEO of Wellcome plc's Japan-based subsidiary Nippon Wellcome K.K., Cipau was employed at Burroughs Wellcome in the U.S. from 1970 to 1993, where he managed pilot plant operations, project engineering, technical operations, production and engineering. Copley founder and former Chairman and CEO Jane Hirsh will become president of the newly created international business. Mark Hirsh remains Copley exec VP-marketing and business development...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning